Yes. The profile covers several Helse-NIM concepts already, but I’d consider these additions:

[ ] End date: add support for FHIR abatement[x] (the optional “Sluttdato”) with a Norwegian definition. It is not present in the profile.

[ ] Severity of the reaction: support reaction.severity separately from criticality. The guide distinguishes severity of the overall allergy from how severe a reaction the patient experienced.

[ ]Reaction details: mark reaction and reaction.manifestation as supported, and consider the guide’s recommended KJ 7497 “Reaksjonstype” terminology for manifestations. The example already has a manifestation, but the profile does not explicitly describe or constrain reaction details.

[ ] Agent coding: the guide says the choice depends on the implementation, and recommends drug-brand or active-substance identifiers for medicines; KJ 7514 is for other agent types. The profile currently binds code to KJ 7514 alone, so consider how medicinal agents and the existing allergen value set will be supported too.
The guide’s Innholdsstatus covers “no known allergies” or missing allergy information. That belongs at the allergy-list or section level, not as a field on an individual AllergyIntolerance.

You already cover clinical status, verification status, overall criticality, start-date definition, documentation date, and comment in demo-at-AllergyIntolerance.fsh:19-44. I’d treat the additions above as support and terminology decisions, not assume the guide makes every field mandatory. The page is still marked as a draft and was published for external consultation, so its recommendations should be read in that context: Helse-NIM for overfølsomhet.